WO2007082866A3 - Use of chavicol for the treatment of superfinfected oily skin and scalp - Google Patents

Use of chavicol for the treatment of superfinfected oily skin and scalp Download PDF

Info

Publication number
WO2007082866A3
WO2007082866A3 PCT/EP2007/050348 EP2007050348W WO2007082866A3 WO 2007082866 A3 WO2007082866 A3 WO 2007082866A3 EP 2007050348 W EP2007050348 W EP 2007050348W WO 2007082866 A3 WO2007082866 A3 WO 2007082866A3
Authority
WO
WIPO (PCT)
Prior art keywords
scalp
treatment
oily skin
chavicol
superfinfected
Prior art date
Application number
PCT/EP2007/050348
Other languages
French (fr)
Other versions
WO2007082866A2 (en
Inventor
Carlo Ghisalberti
Original Assignee
Polichem Sa
Carlo Ghisalberti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polichem Sa, Carlo Ghisalberti filed Critical Polichem Sa
Publication of WO2007082866A2 publication Critical patent/WO2007082866A2/en
Publication of WO2007082866A3 publication Critical patent/WO2007082866A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/08—Oxygen or sulfur directly attached to an aromatic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Chavicol has been found to possess a dual-action in the treatment of superinfected oily skin and scalp by sebum reduction coupled with biocidal activity on lipophilic anaerobic micro-organisms, whilst possessing no significant estrogenic nor sensitizing potentials. It is thus indicated for the manufacture of orally or topically administrable compositions for the treatment of superinfected oily skin and/or scalp and, in particular, for the treatment of androgenic disorders of skin and/or scalp such androgenic disorders incude alopecia, acne, seborrhea and/or dandruff.
PCT/EP2007/050348 2006-01-20 2007-01-15 Use of chavicol for the treatment of superfinfected oily skin and scalp WO2007082866A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2006000087 2006-01-20
IBPCT/IB2006/000087 2006-01-20

Publications (2)

Publication Number Publication Date
WO2007082866A2 WO2007082866A2 (en) 2007-07-26
WO2007082866A3 true WO2007082866A3 (en) 2008-03-13

Family

ID=36928806

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/EP2007/050345 WO2007082864A2 (en) 2006-01-20 2007-01-15 Use of chavicol as an antiseptic
PCT/EP2007/050348 WO2007082866A2 (en) 2006-01-20 2007-01-15 Use of chavicol for the treatment of superfinfected oily skin and scalp

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/EP2007/050345 WO2007082864A2 (en) 2006-01-20 2007-01-15 Use of chavicol as an antiseptic

Country Status (1)

Country Link
WO (2) WO2007082864A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004206769B2 (en) 2003-01-24 2009-11-26 Stiefel Research Australia Pty Ltd Clindamycin phosphate foam
US10568859B2 (en) 2009-02-25 2020-02-25 Mayne Pharma Llc Topical foam composition
US20130156708A1 (en) * 2011-12-20 2013-06-20 Symrise Ag Phenol derivatives as antimicrobial agents
DE102016125344A1 (en) * 2016-12-22 2018-06-28 Peter Jürgensen Preparation for use in the treatment of hereditary hair loss
KR101935904B1 (en) * 2017-07-27 2019-01-07 주식회사 엑티브온 A preservative for skin external application, and a cosmetic composition and a pharmaceutical composition comprising the same

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003082233A1 (en) * 2002-04-03 2003-10-09 Carlo Ghisalberti Allyl-phenol compounds in androgenic disorders

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003082233A1 (en) * 2002-04-03 2003-10-09 Carlo Ghisalberti Allyl-phenol compounds in androgenic disorders

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHAUMONT ET AL: "Antifungal properties of some phenols and very similar chemical compounds. Structure-activity relations", PLANTES MEDICINALES ET PHYTOTHERAPIE, ANGERS, FR, vol. 23, no. 2, 1989, pages 124 - 128, XP008086361, ISSN: 0032-0994 *
EYKMAN ET AL: "Ethereal oil of betel-leaves", BERICHTE DER DEUTSCHEN CHEMISCHEN GESELLSCHAFT, VERLAG CHEMIE. WEINHEIM, DE, vol. 58, 1890, pages 135 - 136, XP002461225 *

Also Published As

Publication number Publication date
WO2007082864A2 (en) 2007-07-26
WO2007082866A2 (en) 2007-07-26
WO2007082864A3 (en) 2008-02-07

Similar Documents

Publication Publication Date Title
WO2007082866A3 (en) Use of chavicol for the treatment of superfinfected oily skin and scalp
AU2008281460A8 (en) Continuous spray sunscreen compositions
WO2001078706A3 (en) Treatment of hyperproliferative, inflammatory and related mucocutaneous disorders using inhibitors of mevalonate synthesis and metabolism
WO2007002862A3 (en) Compositions and methods for treatment of cycle-related symptoms
EP1727530A4 (en) Topical formulations for the treatment of skin conditions
WO2006120682A3 (en) Compositions and methods for treating hyperproliferative epidermal diseases
GB2465703B (en) Cosmetic treatment using p-coumaric acid derivatives for the reduction of skin pigmentation
EP2455134A3 (en) Magnolia extract containing compositions
WO2007065289A3 (en) 4-oxo-(iso)tretinoin for the topical treatment of severe dermatological disorders
WO2004091483A3 (en) Once daily formulations of tetracyclines
ZA200810113B (en) Method for the treatment and prevention of ocular disorders
WO2005115395A3 (en) Compounds, formulations, and methods for treating or preventing inflammatory skin disorders
WO2007053844A3 (en) Compositions and methods for treating inflammatory disorders
MXPA06012143A (en) Arylsulfonamides and uses related thereto.
WO2004000230A3 (en) Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders
WO2010088450A3 (en) Arylamide derivatives useful in the treatment of diseases associated with serca activity
TW200407312A (en) Preparations for topical administration of substances having antiandrogenic activity
JP2008513426A5 (en)
EP1636160A4 (en) Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders
JP2008513427A5 (en)
WO2004087083A3 (en) Reduction of hair growth
PL378210A1 (en) Use of steroids to treat ocular disorders
WO2006136428A3 (en) Method and composition to treat skin ulcers
WO2008013791A3 (en) Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal
WO2007127421A3 (en) Process for the synthesis of (+) and (-)-1-aryl-3-azabicyclo[3.1.0]hexanes

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE